Genentech, along with the Breast International Group, Breast European Adjuvant Study Team and Frontier Science Foundation, recently reported positive results from the Phase III Aphinity study for combining Perjeta, Herceptin and chemotherapy in treating certain breast cancer patients. Read More »
McKesson Corp. and Change Healthcare Holdings Inc. have completed their agreement to build a new health care information technology company titled Change Healthcare. Read More »
The American Society of Health-System Professionals recently announced that the United States updated the Common Rule, a federal regulation that supports research involving human subjects. Read More »
Biogen will present data on its treatments and investigational treatments for people with multiple sclerosis, spinal muscular atrophy and Alzheimer’s disease at the upcoming American Academy of Neurology annual meeting in Boston. Read More »
Bedside delivery of medications is a practice that is helping patients live more healthily following discharge from hospitals. Read More »
ALK's house dust mite (HDM) sublingual allergy immunotherapy tablet has been approved in 12 European countries, to include availability for adolescent patients. Read More »
The U.S. FDA has issued a letter in response to the New Drug Application for baricitinib, rejecting the application. Read More »
Allergan PLC and Ironwood Pharmaceuticals Inc. merged forces with the American Gastroenterological Association to raise awareness about bowel health during Irritable Bowel Syndrome Awareness Month. Read More »
The U.S. Food and Drug Administration has approved two applications for treatments of hepatitis C in children. Read More »
Endo International announced April 12 a $300 million aggregate principal amount of 5.875% senior secured notes which will be due in 2024 at the price of $1000 for each $1000 principal amount, as related to their prior announcement of private offering. Read More »
An analysis commissioned by Washington, D.C.’s Pharmaceutical Care Management Association (PCMA) recently confirmed that no correlation exists between prices and rebates contrary to claims that drug costs are proportional to consumer rebates and discounts. Read More »
Imprimis Pharmaceuticals Inc. this month gained the rights to Klarity, a new remedy for dry eye disease (DED). Read More »
Amgen recently unveiled new data from the Kyprolis and Xgeva clinical development programs at the 16th International Myeloma Workshop in New Delhi. Read More »
A majority of the biggest patient advocacy groups in the country received drug industry funding last year, with many receiving as much as $1 million or more, a study has found. Read More »
The Academy of Managed Care Pharmacy (AMCP) recently applauded Rep. Brett Guthrie's (R-KY) Pharmaceutical Information Exchange (PIE) Act of 2017 and its efforts toward its passage. Read More »
Ingrezza (valbenazine) has been approved by the Food and Drug Administration for the treatment of tardive dyskinesia in adults. Read More »
A recent Walgreens study points to a connection between pharmacy communication and patient adherence. Read More »
CVS Health's Advanced Care Scripts has earned accreditation in Specialty Pharmacy from URAC, the leader in health care accreditation, certification and overall measurement. Read More »
Amgen's results from its Phase 3 Tower study evaluating Blincyto’s efficacy have been published in the New England Journal of Medicine. Read More »
Merck & Co. Inc. recently released the results of its Phase 3 clinical study of letermovir, a drug used to prevent clinically significant cytomegalovirus infection in CMV-seropositive adult recipients of an allogeneic hematopoietic stem cell transplant, also known as bone marrow transplant. Read More »
Alerts Sign-up
